Sequence Symmetry Analysis of the Interrelationships Between Ramelteon and Parkinson's Disease
Journal of Pineal Research · 2025-09 · 77 (5)
DOI: 10.1111/jpi.70080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pineal Research, online erschienen am 14.09.2025. Verfasst von Yoshihiro Noguchi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan. Hauptthemen laut MEDLINE: Parkinson Disease, Indenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: This study was supported by JSPS KAKENHI, 22K12890..
Abstract (Originalsprache)
Parkinson's disease is the second most frequent neurodegenerative disease after Alzheimer's disease, and the most common neurodegenerative disease that causes movement dysfunction. Without innovations in prevention and treatment, the incidence and prevalence of Parkinson's disease is projected to increase by > 30% by 2030, making the development of new treatments an urgent priority. We previously investigated the association between melatonin receptor agonists and Parkinson's disease using the US Food and Drug Administration's Adverse Event Reporting System (FAERS). The results showed that ramelteon may reduce the incidence of Parkinson's disease. However, since the US FAERS relies on spontaneous reports, which are susceptible to reporting bias, further validation using real‐world data is required. This study investigated the association between ramelteon use and risk of developing Parkinson's disease using the DeSC database, a Japanese claims database reported to be representative of the general Japanese population. The association was evaluated using sequence symmetry analysis, with the adjusted sequence ratio (ASR) serving as the evaluation index. Our DeSC database analysis showed a negative association between ramelteon use and Parkinson's disease (ASR: 0.959, 95% confidence interval: 0.955–0.964). Our results support previous reports suggesting that ramelteon may help suppress the onset of Parkinson's disease. However, even though this study used real‐world data, these results should be interpreted with caution, as a sequence symmetry analysis cannot be adjusted for covariates. Therefore, additional pharmacoepidemiological studies are needed to further verify the potential risk of Parkinson's disease associated with ramelteon use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.
ORCID-Profile: Yoshihiro Noguchi, Rikuto Masuda, Tomoaki Yoshimura
Förderung
- This study was supported by JSPS KAKENHI, 22K12890.
Zitieren
APA
Noguchi, Y., Masuda, R., & Yoshimura, T. (2025). Sequence Symmetry Analysis of the Interrelationships Between Ramelteon and Parkinson's Disease. Journal of Pineal Research, 77(5). https://doi.org/10.1111/jpi.70080
Vancouver
Noguchi Y, Masuda R, Yoshimura T. Sequence Symmetry Analysis of the Interrelationships Between Ramelteon and Parkinson's Disease. Journal of Pineal Research. 2025;77(5). doi:10.1111/jpi.70080
BibTeX
@article{Noguchi2025,
author = {Noguchi, Yoshihiro and Masuda, Rikuto and Yoshimura, Tomoaki},
title = {Sequence Symmetry Analysis of the Interrelationships Between Ramelteon and Parkinson's Disease},
journal = {Journal of Pineal Research},
year = {2025},
volume = {77},
number = {5},
doi = {10.1111/jpi.70080}
}
EUVIMED